Subsidiary ER Decides 7.96B Won Capital Increase... ALUX Contributes ER VINA Stake In-Kind, Restructuring Ownership
Subsidiary ER decides a rights offering of 730,131 shares (issue price 10,900 won) totaling 7.96 billion won.
ALUX will contribute its 85.66% stake in ER VINA to ER as an in-kind contribution, receiving new shares in return.
The capital increase aims to expand ER's capital base and simplify ALUX's ownership structure without diluting existing shareholders.
Payment date postponed to July 31, 2026 due to court review delay.
[AI Comprehensive Analysis]This capital increase is a strategic restructuring to improve financial efficiency within the group, with no dilution risk for ALUX shareholders. However, the valuation of the in-kind asset and court approval schedule should be monitored as investment risks.
KOSDAQ Filing Information
Filing: [Correction of Description] Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary)